Enjoy complimentary customisation on priority with our Enterprise License!
Technavio’s market research analysts predict the global diabetic therapeutic market to grow steadily during the forecast period and post a CAGR of more than 7% by 2021. This industry research report identifies the increasing focus on the self-management of diabetes to be one of the major factors that will have a positive impact on the growth of this market in the coming years. With the recent years witnessing an increase in number of people diagnosed with type 1 diabetes, there has been considerable increase in the adoption of insulin delivery systems. Focusing on skipping the need to schedule appointments and reduce expenses for clinical visits, increases the adoption of insulin delivery systems, where individuals use insulin injections at home under the guidance of a physician. This led to the introduction of insulin pens, pumps, and jet injectors, which, in turn, will drive the growth of the diabetic therapeutics market.
In terms of geographical regions, the Americas will be the major revenue contributor to the diabetic therapeutics market throughout the predicted period. The increasing prevalence of diabetes in countries such as the US, which provides opportunities for vendors to develop new, more efficient, and safer drugs will be the major factor driving market growth in this segment.
Characterized by the presence of numerous small and large-scale vendors, the diabetes treatment market appears to be highly competitive. The market is dominated by the major players such as AstraZeneca, Novo Nordisk, Merck, Eli Lilly, and Sanofi who are competing against each other to lead the market. The market also consists of a number of local manufacturers in various countries and will also witness the entry of several new players, which will further intensify the level of competition in the market. To increase their revenue shares and improve market position, vendors are focusing on strategic alliances which will help them in marketing and manufacturing drugs.
The leading vendors in the market are
During 2016, the type 1 diabetes segment accounted for the major shares and dominated the market. The increase in the global population diagnosed with type 1 diabetes and the rising awareness of the disease will be major factors aiding the growth of this market segment in the coming years.
Insulin therapies are mostly adopted for the most advanced stage of diabetes and are used to compensate for the inadequate production of endogenous insulin. According to the diabetes treatment market research and analysis, the insulin therapies segment accounted for the major shares and dominated the market during 2016.
Want a bigger picture? Try a FREE sample of this report now!
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Technavio also offers customization on reports based on specific client requirement.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Disease overview: Diabetes
PART 06: Pipeline portfolio
PART 07: Market landscape
PART 08: Overview of marketed products
PART 09: Market segmentation by type of disease
PART 10: Market segmentation by drug class
PART 11: Geographical segmentation
PART 12: Market drivers4
PART 13: Impact of drivers
PART 14: Market challenges
PART 15: Impact of drivers and challenges
PART 16: Market trends
PART 17: Vendor landscape8
PART 18: Key vendor analysis
PART 19: Appendix
PART 20: Explore Technavio
Tags: gestational diabetes, diabetic food, blood pressure monitor, ambulatory blood pressure monitoring, healthcare industry trends, medical devices market study,
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.